PURCHASE, NY, Feb. 26, 2018 -- HIMSS Booth #3860 - Teladoc, Inc. (NYSE:TDOC) the world’s largest and most trusted provider of virtual care delivery services, announced today that it has been certified as a trusted partner of Surescripts,® the nation’s leading health information network. With this certification Teladoc expands its e-prescribing relationship with the organization, enabling Teladoc physicians to access the Surescripts Medication History and Eligibility & Formulary services. Real-time medication history validation and prescription benefit access at the time of consultation gives Teladoc physicians greater data insights that ultimately lead to improved medication adherence, reduced risk of potential adverse drug interactions, and lower prescription costs for patients.
“By leveraging the vast Surescripts health information network, we are demonstrating the power that data-sharing, when applied to virtual care delivery at scale, can have on assuring clinical quality and value for our members,” said Lewis Levy, MD, chief medical officer, Teladoc.
At a time when preventable medication errors impact more than seven million US patients annually, the addition of Surescripts’ Medication History service to Teladoc’s virtual care delivery platform is an example of how data sharing can eliminate prescription errors that lead to adverse drug events. By informing treating physicians of members’ current and past prescriptions, Teladoc is providing important information that enables physicians to account for potential drug interactions or allergic reactions when prescribing medication.
Furthermore, Teladoc physicians can now view in real-time the member’s drug formulary data including cost information during a patient visit. This enables Teladoc physicians to save money for patients by reducing out-of-pocket costs, while also improving overall medication compliance.
Being certified as a trusted partner of Surescripts is another example of how Teladoc continues to lead the industry in data-sharing across the healthcare ecosystem. With the ability to access real-time pharmacy information, to integrate into EMR systems, and to share medical records with primary care physicians, Teladoc goes beyond point-in-time care, to become a true part of the overall healthcare journey.
“While the healthcare industry has historically lagged in information sharing, completing this rigorous certification process with Surescripts is another example of the high level of interoperability we have at Teladoc,” says Jeff Nadler, chief information officer, Teladoc.
For more information, visit Teladoc.com.
About Teladoc, Inc.
Teladoc, Inc. (NYSE:TDOC) is the world’s largest and most trusted provider of virtual healthcare delivery services. Recognized by MIT Technology Review as one of the “50 Smartest Companies”, Teladoc is forging a new healthcare experience with better convenience, outcomes and value. The company provides virtual access to high quality care and expertise with a portfolio of services and solutions – inclusive of coverage of 450 medical subspecialties – that spans the spectrum from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. By marrying the latest in data and analytics with its award-winning user experience and highly flexible technology platform, Teladoc has delivered millions of medical visits to patients around the globe. For additional information, please visit www.teladoc.com.
Media Contact:
Courtney McLeod
Director, Communications, Teladoc
914-265-6789
[email protected]


Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Shein Scales Back Vietnam Operations as US Trade Rules Shift
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 



